![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Stasi Roberto
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.68, Iss.7, 2008-01, pp. : 901-912
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Management of Immune Thrombocytopenic Purpura in Children: Potential Role of Novel Agents
By >
Pediatric Drugs, Vol. 13, Iss. 4, 2011-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Emerging drugs for idiopathic thrombocytopenic purpura in adults
Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. :